한글목차

세계의 3D 바이오프린팅 시장 규모는 2025년에 29억 5,000만 달러로 추정되며, 2032년에는 85억 3,000만 달러에 달할 것으로 예상되며, 2025-2032년 연평균 16.4%의 성장률을 보일 것으로 예상됩니다.

그림.3D 바이오프린팅 시장 점유율(%), 2025년, 지역별

보고서 개요:

3D 바이오프린팅은 3D 프린터를 이용하여 의료 연구 및 임상 응용을 위해 인체 조직, 장기, 생화학 물질을 인쇄하는 신흥 혁신 기술입니다. 살아있는 세포, 스캐폴더, 생체조직의 형성을 지원하는 성장인자를 적층하여 작동합니다. 이 선구적인 접근 방식은 이식 가능한 장기의 부족을 해결함으로써 헬스케어에 혁명을 일으킬 수 있는 큰 잠재력을 가지고 있습니다. 컴퓨터 지원 설계에 기반한 생체 재료, 살아있는 세포 및 보조 인자의 정확한 공간적 증착을 통해 복잡한 3D 조직 및 장기 구조를 제작할 수 있습니다. 조직과 장기의 원래 미세 환경을 재현함으로써 3D 바이오프린팅은 재생의료 분야를 가속화하고 궁극적으로 장기 이식 수요에 대응할 수 있습니다.

시장 역학:

세계 3D 바이오프린팅 시장은 재생의학 연구를 위한 자금 조달과 구상 증가에 힘입어 성장하고 있습니다. 장기 이식에 대한 수요 증가와 기증자 부족으로 인해 바이오프린팅 기술이 제공하는 대체 솔루션에 대한 투자가 증가하고 있습니다. 유리한 규제 지침과 바이오프린팅 조직의 상용화는 유리한 기회를 창출하고 있습니다. 그러나 복잡한 생체 구조를 인쇄할 때 높은 운영 비용과 기술적 어려움이 제약요인으로 작용하고 있습니다. 또한 숙련된 전문 지식과 임상시험의 부족도 보급에 걸림돌이 되고 있습니다. 그럼에도 불구하고 기업은 생체 재료, 세포 적합성, 3D 바이오 프린터의 해상도를 개선하기 위해 협력하고 있습니다. 약동학 시험, 맞춤형 약물 스크리닝, 희귀질환 모델링과 같은 새로운 용도의 출현은 예측 기간 중 시장 성장을 가속할 수 있습니다.

본 조사의 주요 특징

• 세계의 3D 바이오프린팅 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR%)을 조사하여 전해드립니다.
• 또한 다양한 부문에 걸친 잠재적인 매출 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
• 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 3D 바이오프린팅 시장의 주요 업체를 프로파일링합니다.
• 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 3D 바이오프린팅 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 3D 바이오프린팅 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차 :

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 리포트 설명
  • 시장의 정의와 범위
• 개요
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품의 발매/승인
• PEST 분석
• Porter의 산업 분석
• 합병과 인수 시나리오

제4장 세계의 3D 바이오프린팅 시장 : COVID-19 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측 분석
• 경제에 대한 영향

제5장 세계의 3D 바이오프린팅 시장 : 기술별(2020-2032년)

• 시린지식/압출 바이오프린팅
• 잉크젯 바이오프린팅
• 자기 부상 바이오프린팅
• 레이저 어시스트 바이오프린팅
• 기타 기술

제6장 세계의 3D 바이오프린팅 시장 : 컴포넌트별(2020-2032년)

• 3D 바이오프린터
• 바이오소재
• 스캐폴드

제7장 세계의 3D 바이오프린팅 시장 : 용도별(2020-2032년)

• 의약품 시험과 개발
• 재생의료
• 식품 검사
• 연구
• 기타 용도

제8장 세계의 3D 바이오프린팅 시장 : 지역별(2020-2032년)

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제9장 경쟁 구도

• 기업 개요
  • 3D Bioprinting Solutions
  • Advanced Solutions Life Sciences, LLC
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bico group ab
  • Bio3D Technologies Pte. Ltd.
  • Cellink Global
  • Collplant Biotechnologies Ltd.
  • Cyfuse Biomedical KK
  • Electro Optical Systems
  • Envisiontec GmbH
  • Foldink Life Science Technologies
  • Formlabs, Inc.
  • GE Healthcare
  • Inventia Life Science PTY LTD
  • Nano 3D Biosciences, Inc.
  • Optomec Inc.
  • Organovo Holdings, Inc.
  • Pandorum Technologies pvt. ltd.
  • Precise Bio
  • Regemat 3D SL
  • Regenovo Biotechnology Co. Ltd.
  • Renishaw PLC.
  • Revotek Co., Ltd.
  • Rokit Healthcare, Inc.
  • Stratasys Ltd.
  • Vivax Bio, LLC

제10장 운명의 수레바퀴

• 운명의 수레바퀴
• 애널리스트의 견해
• Coherent Opportunity Map(COM)

제11장 섹션 :

• 조사 방법
• 출판사 소개

영문목차

Global 3d Bioprinting Market is estimated to be valued at USD 2.95 Bn in 2025 and is expected to reach USD 8.53 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.4% from 2025 to 2032.

Figure. 3d Bioprinting Market Share (%), By Region 2025

Report Description:

3D bioprinting is an emerging and innovative technology that utilizes 3D printers to print human tissues, organs, and biochemicals for medical research and clinical applications. It works by layering live cells, scaffolds, and growth factors capable of supporting the formation of biological tissues. This pioneering approach holds enormous potential in revolutionizing healthcare by addressing the shortage of transplantable organs. It allows the fabrication of complex 3D tissues and organ structures through precise spatial deposition of biomaterials, living cells, and supporting factors based on computer-assisted design. By replicating the native microenvironment of tissues and organs, 3D bioprinting can accelerate the field of regenerative medicine and ultimately address the demand for organ transplants.

Market Dynamics:

The global 3D bioprinting market is driven by rising funding and initiatives for research in regenerative medicines. The growing demand for organ transplants and lack of donors has boosted investments in alternative solutions offered by bioprinting technologies. Favorable regulatory guidelines and commercialization of bioprinted tissues are creating lucrative opportunities. However, high operational costs and technical challenges in printing complex living structures pose constraints. Lack of skilled expertise and clinical trials also challenge widespread adoption. Nonetheless, companies are collaborating to improve biomaterials, cell compatibility, and resolution of 3D bioprinters. The emergence of newer application areas such as pharmacokinetic testing, personalized drug screening, and rare disease modeling can boost the market growth during the forecast period.

Key Features of the Study:

• This report provides an in-depth analysis of the global 3D bioprinting market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global 3D bioprinting market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include 3D Bioprinting Solutions, Advanced Solutions Life Sciences, LLC, Allevi Inc., Aspect Biosystems Ltd., Bico group ab, Bio3D Technologies Pte. Ltd., Cellink Global, Collplant Biotechnologies Ltd., Cyfuse Biomedical K.K., Electro Optical Systems, Envisiontec GmbH, Foldink Life Science Technologies, Formlabs, Inc., GE Healthcare, Inventia Life Science PTY LTD, Nano 3D Biosciences, Inc., Optomec Inc., Organovo Holdings, Inc., Pandorum Technologies pvt. ltd., Precise Bio, Regemat 3D S.L., Regenovo Biotechnology Co. Ltd., Renishaw plc., Revotek co., ltd., Rokit Healthcare, inc., Stratasys Ltd.Vivax Bio, LLC, and Vivax Bio, LLC
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global 3D bioprinting market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global 3D bioprinting market

Market Segmentation

• By Technology
  • Syringe/extrusion Bioprinting
  • Inkjet Bioprinting
  • Magnetic Levitation Bioprinting
  • Laser-assisted Bioprinting
  • Others
• By Component
  • 3D Bioprinters
  • Biomaterials
  • Scaffolds
• By Application
  • Drug Testing and Development
  • Regenerative Medicine
  • Food Testing
  • Research
  • Others
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Israel
  • Rest of Middle East & Africa
• Key Players Insights
  • 3D Bioprinting Solutions
  • Advanced Solutions Life Sciences, LLC
  • Allevi Inc.
  • Aspect Biosystems Ltd.
  • Bico group ab
  • Bio3D Technologies Pte. Ltd.
  • Cellink Global
  • Collplant Biotechnologies Ltd.
  • Cyfuse Biomedical K.K.
  • Electro Optical Systems
  • Envisiontec GmbH
  • Foldink Life Science Technologies
  • Formlabs, Inc.
  • GE Healthcare
  • Inventia Life Science PTY LTD
  • Nano 3D Biosciences, Inc.
  • Optomec Inc.
  • Organovo Holdings, Inc.
  • Pandorum Technologies pvt. ltd.
  • Precise Bio
  • Regemat 3D S.L.
  • Regenovo Biotechnology Co. Ltd.
  • Renishaw plc.
  • Revotek co., ltd.
  • Rokit Healthcare, inc.
  • Stratasys Ltd.Vivax Bio, LLC
  • Vivax Bio, LLC

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Component
  • Market Snapshot, By Application
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunity
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global 3D Bioprinting Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global 3D Bioprinting Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Syringe/ extrusion bioprinting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inkjet Bioprinting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Magnetic Levitation Bioprinting
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Laser Assisted Bioprintings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Technologies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global 3D Bioprinting Market, By Component, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• 3D Bioprinters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Biomaterials
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Scaffolds
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global 3D Bioprinting Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Drug Testing and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Food Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global 3D Bioprinting Market, By Region, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Country Trends
• North America
  • Regional Trends
  • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
  • Market Share Analysis, By Country, 2025 and 2032 (%)
    • U.S.
    • Canada
• Europe
  • Regional Trends
  • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
  • Market Share Analysis, By Country, 2025 and 2032 (%)
    • U.K.
    • Germany
    • France
    • Russia
    • Rest of Europe
• Asia Pacific
  • Regional Trends
  • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
  • Market Share Analysis, By Country, 2025 and 2032 (%)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Regional Trends
  • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
  • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East & Africa
  • Market Size and Forecast, By Technology, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Components, 2020-2032 (USD Billion)
  • Market Size and Forecast, By Application, 2020-2032 (USD Billion)
  • Market Share Analysis, By Country/region, 2025 and 2032 (%)
    • South Africa
    • GCC Countries
    • Rest of the Middle East & Africa

9. Competitive Landscape

• Company Profiles
  • 3D Bioprinting Solutions*
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Advanced Solutions Life Sciences, LLC
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Allevi Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Aspect Biosystems Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Bico group ab
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Bio3D Technologies Pte. Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Cellink Global
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Collplant Biotechnologies Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Cyfuse Biomedical K.K.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Electro Optical Systems
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments/Updates
  • Envisiontec GmbH
  • Foldink Life Science Technologies
  • Formlabs, Inc.
  • GE Healthcare
  • Inventia Life Science PTY LTD
  • Nano 3D Biosciences, Inc.
  • Optomec Inc.
  • Organovo Holdings, Inc.
  • Pandorum Technologies pvt. ltd.
  • Precise Bio
  • Regemat 3D S.L.
  • Regenovo Biotechnology Co. Ltd.
  • Renishaw PLC.
  • Revotek Co., Ltd.
  • Rokit Healthcare, Inc.
  • Stratasys Ltd.
  • Vivax Bio, LLC

10. Wheel of Fortune

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Section:

• Research Methodology
• About Us